Table 6

 Anxiety and depression levels during treatment with citalopram or placebo, assessed using the hospital anxiety and depression scale (HAD) and symptom checklist-90-revised (SCL-90R)

Before citalopramCitalopram 3 weeksCitalopram 6 weeksBefore placeboPlacebo 3 weeksPlacebo 6 weeks
*Significant compared with run in: p<0.05.
†Significant compared with placebo: p<0.05.
Anxiety (HAD)11.4 (1.1)10.7 (1.0)*†9.6 (0.8)*†13.1 (0.9)12.4 (1.0)*11.0 (1.1)*
Depression (HAD)6.0 (0.9)3.8 (0.6)*†3.7 (0.7)*†6.3 (1.0)6.3 (0.9)6.0 (0.9)
Anxiety (SCL-90R)17.7 (1.8)15.5 (1.6)14.9 (1.6)16.8 (1.8)16.4 (1.8)16.3 (1.9)
Depression (SCL-90R)31.5 (3.3)29.1 (2.8)28.6 (2.9)31.2 (3.3)32.0 (3.2)30.1 (3.3)